Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 1, 2006, Pages 65-72

  Roncella, Silvio ^a   Ferro, P ^a   Bacigalupo, B ^a   Dessanti, P ^a   Giannico, A ^a   Gorji, N ^a   Moroni, M ^a   Tozzini, S ^a   Pensa, F ^a   Gianquinto, D ^a   Fais, F ^b   Pronzato, P ^a   Fedeli, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Breast cancer; Clinico pathologic prognostic factors; Human mammaglobin; Reverse transcriptase polymerase chain reaction

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCOPROTEIN; MAMMAGLOBIN; MESSENGER RNA; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CELL LINE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, PROGESTERONE; RNA, MESSENGER; UTEROGLOBIN;

EID: 33646108577     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Watson M.A., Fleming T.P.: Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 56:860-865, 1996.
2. Ni J., Kalff-Suske M., Gentz R., Schageman J., Beato M., Klug J.: All human genes of the uteroglobin family are localized on chromosome 11q12.2 and form a dense cluster. Ann. N. Y. Acad. Sci. 923:25-42, 2000.
3. Watson M.A., Darrow C., Zimonjic D.B., Popescu N.C., Fleming T.P.: Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene 16:817-824, 1998.
4. Colpitts T.L., Billing-Medel P., Friedman P., et al.: Mammaglobin is found in breast tissue as a complex with BU101. Biochemistry 40:11048-11059, 2001.
5. Watson M.A., Dintzis S., Darrow C.M., et al.: Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res. 59:3028-3031, 1999.
6. Grunewald K., Haun M., Fiegl M., et al.: Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction. Lab. Invest. 82:1147-1153, 2002.
7. O'Brien N., Maguire T.M., O'Donovan N., et al.: Mammaglobin a: a promising marker for breast cancer. Clin. Chem. 48:1362-1364, 2002.
8. Zehentner B.K., Carter D.: Mammaglobin: a candidate diagnostic marker for breast cancer. Clin. Biochem. 37:249-257, 2004.
9. Leygue E., Snell L., Dotzlaw H., et al.: Mammaglobin, a potential marker of breast cancer nodal metastasis. J. Pathol. 189:28-33, 1999.
10. Marchetti A., Buttitta F., Bertacca G., et al.: mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. J. Pathol. 195:186-190, 2001.
11. Corradini P., Voena C., Astolfi M., et al.: Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer. Ann. Oncol. 12:1693-1698, 2001.
12. Ooka M., Tamaki Y., Sakita I., et al.: Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer. Breast Cancer Res. Treat. 67:169-175, 2001.
13. Grunewald K., Haun M., Urbanek M., et al.: Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab. Invest. 80:1071-1077, 2000.
14. Hu X.C., Chow L.W.: Detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction (RT-PCR). Eur. J. Surg. Oncol. 26:530-535, 2000.
15. Lin Y.C., Wu Chou Y.H., Liao I.C., Cheng A.J.: The expression of mammaglobin mRNA in peripheral blood of metastatic breast cancer patients as an adjunct to serum tumor markers. Cancer Lett. 191:93-99, 2003.
16. Suchy B., Austrup F., Driesel G., et al.: Detection of mammaglobin expressing cells in blood of breast cancer patients. Cancer Lett. 158:171-178, 2000.
17. Zach O., Kasparu H., Krieger O., Hehenwarter W., Girschikofsky M., Lutz D.: Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J. Clin. Oncol. 17:2015-2019, 1999
18. Goedegebuure P.S., Watson M.A., Viehl C.T., Fleming T.P.: Mammaglobin-based strategies for treatment of breast cancer. Curr. Cancer Drug. Targets 4:531-542, 2004.
19. Narayanan K., Jaramillo A., Benshoff N.D., et al.: Response of established human breast tumors to vaccination with mammaglobin-A cDNA. J. Natl Cancer Inst. 96:1388-1396, 2004.
20. Tanaka Y., Amos K.D., Fleming T.P., Eberlein T.J., Goedegebuure P.S.: Mammaglobin-A is a tumor-associated antigen in human breast carcinoma. Surgery 133:74-80, 2003.
21. Guan X.F., Hamedani M.K., Adeyinka A., et al.: Relationship between mammaglobin expression and estrogen receptor status in breast tumors. Endocrine 21:245-250, 2003.
22. Nunez-Villar M.J., Martinez-Arribas F., Pollan M., et al.: Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype. Breast Cancer Res. 5:R65-70, 2003.
23. Span P.N., Waanders E., Manders P., et al.: Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. J. Clin. Oncol. 22:691-698, 2004.
24. Elston C.W., Ellis I.O.: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410, 1991.
25. Roncella S., Ferro P., Bacigalupo B., et al.: Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood. J. Exp. Clin. Cancer Res. 24:265-272, 2005.
26. Zhang Z., Kundu G.C., Panda D., et al.: Loss of transformed phenotype in cancer cells by overexpression of the uteroglobin gene. Proc. Natl. Acad. Sci. USA 96:3963-3968, 1999.
27. Jesudasan R.A., Rahman R.A., Chandrashekharappa S., Evans G.A., Srivatsan E.S.: Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines. Am. J. Hum. Genet. 56:705-715, 1995.
28. Linnoila R.I., Jensen S.M., Steinberg S.M., Mulshine J.L., Eggleston J.C., Gazdar A.F.: Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features. Am. J. Clin. Pathol. 97:233-243, 1992.
29. Peri A., Cordella-Miele E., Miele L., Mukherjee A.B.: Tissue-specific expression of the gene coding for human Clara cell 10-kD protein, a phospholipase A2-inhibitory protein. J. Clin. Invest. 92:2099-2109, 1993.